Cetirizine Hydrochloride 10 mg Tablets Labeling Error Recall
A-S Medication Solutions LLC is recalling Cetirizine hydrochloride 10 mg tablets due to a labeling error: bottles were labeled as 90-count when they actually contain 30 tablets.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: This is a labeling discrepancy involving tablet count without any reported safety hazard, injury, or illness. The source text classifies this as "Not Elsewhere classified" and the FDA classification is Class III, making this a packaging/labeling documentation issue that constitutes a Low severity recall.
Plain-English summary
A-S Medication Solutions LLC is recalling Cetirizine hydrochloride 10 mg tablets due to incorrect labeling. The product was relabeled as a 90-count bottle despite containing only 30 tablets from the manufacturer.
The affected product is Cetirizine hydrochloride 10 mg tablets in 90-count bottles, manufactured by Major Pharmaceuticals (Livonia, MI) and distributed by A-S Medication Solutions (Libertyville, IL). The recalled lot number is 1256330, with 72 bottles distributed across Florida, Indiana, Minnesota, and Wisconsin. The product NDC is 50090-5510-3.
Consumers who have purchased this product should verify the actual tablet count in their bottle matches the label. If the bottle is labeled as 90 tablets but contains fewer tablets, it should not be used. Consumers with questions should contact A-S Medication Solutions.
The recalled product
- Product
- CETIRIZINE (CETIRIZINE HYDROCHLORIDE)
- Brand
- CETIRIZINE
- Manufacturer
- A-S Medication Solutions LLC.
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 1256330
Distribution
Distributed in 4 states:
- FL
- IN
- MN
- WI
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27